Delivery Order SPE2DB22D3501-SPE2DB25FUD91
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,073.59 firm fixed-price contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a medication used in the treatment of respiratory conditions.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $1,604.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone prop HFA 110 mcg 12 gm, a pharmaceutical product.
The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,511.27 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a period of performance through December 3, 2024. The contract award is not designated as a set-aside.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,288.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,620,021 units of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 4, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,071.37 firm fixed price delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a specialty pharmaceutical product.
The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support...
This federal contract award, valued at $18,703.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565740458 - FLUTICASONE PROP HFA 220 MCG 12GM. The contract is a delivery order with a firm fixed price and an ultimate completion date of September 11, 2024. It is not designated as a set-aside contract.
Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.12 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical product to the Defense Logistics Agency (DLA). The $8,793.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $1,685.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4565768852 FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of September 12, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,269.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract has a completion date of August 14, 2024.
The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025....